67 related articles for article (PubMed ID: 7745028)
1. Chronic naltrexone treatment induces desensitization of the luteinizing hormone pulse generator for opioid blockade in hyperprolactinemic patients.
de Wit W; Schoute E; Schoemaker J
J Clin Endocrinol Metab; 1995 May; 80(5):1739-42. PubMed ID: 7745028
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic opioid antagonism on the hypothalamic-pituitary-ovarian axis in hyperprolactinemic women.
Matera C; Freda PU; Ferin M; Wardlaw SL
J Clin Endocrinol Metab; 1995 Feb; 80(2):540-5. PubMed ID: 7852517
[TBL] [Abstract][Full Text] [Related]
3. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
Couzinet B; Young J; Brailly S; Chanson P; Schaison G
J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
[TBL] [Abstract][Full Text] [Related]
4. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
[TBL] [Abstract][Full Text] [Related]
5. Induction of ovulation by the chronic administration of naltrexone in hypothalamic amenorrhea.
Wildt L; Leyendecker G
J Clin Endocrinol Metab; 1987 Jun; 64(6):1334-5. PubMed ID: 3571432
[TBL] [Abstract][Full Text] [Related]
6. Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment.
Armeanu MC; Berkhout GM; Schoemaker J
Fertil Steril; 1992 Apr; 57(4):762-70. PubMed ID: 1555686
[TBL] [Abstract][Full Text] [Related]
7. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
[TBL] [Abstract][Full Text] [Related]
8. [Endocrinological background of pituitary desensitization during pulsatile LH-RH therapy for ovulation induction in amenorrheic women].
Obara M; Mizunuma H; Ibuki Y; Igarashi M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1791-8. PubMed ID: 3323357
[TBL] [Abstract][Full Text] [Related]
9. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
10. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
[TBL] [Abstract][Full Text] [Related]
12. [Induction of ovulation with pulsatile LHRH in anovulatory women].
Masaoka K; Kumasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jun; 36(6):937-46. PubMed ID: 6431037
[TBL] [Abstract][Full Text] [Related]
13. Effects of opioid receptor blockade on luteinizing hormone (LH) pulses and interpulse LH concentrations in normal women during the early phase of the menstrual cycle.
Evans WS; Weltman JY; Johnson ML; Weltman A; Veldhuis JD; Rogol AD
J Endocrinol Invest; 1992; 15(7):525-31. PubMed ID: 1447490
[TBL] [Abstract][Full Text] [Related]
14. Effects of opioid antagonism with naltrexone on pulsatile luteinizing hormone secretion in women with hypothalamic amenorrhea in basal conditions and after discontinuation of treatment with pulsatile LHRH.
Armeanu MC; Lambalk CB; Berkhout GM; Schoemaker J
Gynecol Endocrinol; 1992 Mar; 6(1):3-12. PubMed ID: 1580165
[TBL] [Abstract][Full Text] [Related]
15. [The influence of endogenous opioids in hypothalamic amenorrhea. Diagnostic and therapeutic aspects].
Krause B; Möller S; Ulrich U; Göretzlehner G
Zentralbl Gynakol; 1989; 111(20):1368-73. PubMed ID: 2555982
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
17. Differences in the opioid control of luteinizing hormone secretion between pathological and iatrogenic hyperprolactinemic states.
Petraglia F; De Leo V; Nappi C; Facchinetti F; Montemagno U; Brambilla F; Genazzani AR
J Clin Endocrinol Metab; 1987 Mar; 64(3):508-12. PubMed ID: 2880862
[TBL] [Abstract][Full Text] [Related]
18. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
Quigley ME; Sheehan KL; Casper RF; Yen SS
J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
[TBL] [Abstract][Full Text] [Related]
19. Altered neuroendocrine regulation of gonadotropin secretion in women distance runners.
Veldhuis JD; Evans WS; Demers LM; Thorner MO; Wakat D; Rogol AD
J Clin Endocrinol Metab; 1985 Sep; 61(3):557-63. PubMed ID: 3926810
[TBL] [Abstract][Full Text] [Related]
20. [Ovulation induction by the chronic administration of naltrexone in a patient with secondary hypothalamic amenorrhea].
Sir T; Alba F; Rivera J; Kohen P; Devoto L
Rev Chil Obstet Ginecol; 1992; 57(1):39-43. PubMed ID: 1342427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
